| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0891-5849(01)00697-9 |
| P698 | PubMed publication ID | 11705694 |
| P2093 | author name string | Heinecke JW | |
| McMenamin ME | |||
| Himmelfarb J | |||
| Loseto G | |||
| P2860 | cites work | Oxidants, antioxidants, and the degenerative diseases of aging | Q24561734 |
| Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders | Q33603019 | ||
| An overview of haemodialysis and oxidant stress | Q33712875 | ||
| Pathophysiology of the oxidative stress and its implication in uremia and dialysis | Q33813873 | ||
| Protein oxidation and aging | Q34243989 | ||
| Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells | Q34526444 | ||
| Human neutrophils employ chlorine gas as an oxidant during phagocytosis | Q37359571 | ||
| 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima | Q37366288 | ||
| Leukocytic oxygen activation and microbicidal oxidative toxins | Q38285474 | ||
| The role of oxidized lipoproteins in atherogenesis | Q41043422 | ||
| Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients. | Q43463937 | ||
| Brominating oxidants generated by human eosinophils | Q43746020 | ||
| Detection of granulocyte reactive oxygen species formation in whole blood using flow cytometry | Q44012628 | ||
| Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. | Q45933089 | ||
| Plasma levels of main granulocyte components during hemodialysis. Comparison of new and reused dialyzers. | Q46007944 | ||
| Determinants of albumin concentration in hemodialysis patients | Q46168079 | ||
| Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. | Q50538525 | ||
| Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. | Q50901977 | ||
| A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. | Q51567188 | ||
| Modulation of granulocyte LAM-1 and MAC-1 during dialysis--a prospective, randomized controlled trial | Q67533437 | ||
| Neutrophils convert tyrosyl residues in albumin to chlorotyrosine | Q70911615 | ||
| Advanced oxidation protein products as a novel marker of oxidative stress in uremia | Q71324551 | ||
| The effects of dialyzer reuse on plasma antioxidative mechanisms in patients on regular hemodialysis treatment | Q71561851 | ||
| Detection of oxidants in uremic plasma by electron spin resonance spectroscopy | Q71754537 | ||
| Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils | Q71921090 | ||
| Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial | Q73176018 | ||
| Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes produces 5-chlorocytosine in bacterial RNA | Q73176069 | ||
| Plasma protein thiol oxidation and carbonyl formation in chronic renal failure | Q73293282 | ||
| Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation | Q73898865 | ||
| Oxidative stress in chronic renal failure | Q77226354 | ||
| Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study | Q77410564 | ||
| Oxidative stress during dialysis: effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes | Q77484637 | ||
| Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues | Q77907848 | ||
| Inflammation enhances cardiovascular risk and mortality in hemodialysis patients | Q78163875 | ||
| P433 | issue | 10 | |
| P921 | main subject | renal dialysis | Q202301 |
| P304 | page(s) | 1163-1169 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | Free Radical Biology and Medicine | Q5500023 |
| P1476 | title | Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients | |
| P478 | volume | 31 |
| Q42776527 | 3-Chlorotyrosine in sputum of COPD patients: relationship with airway inflammation |
| Q36544306 | A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation |
| Q27024598 | Antioxidant therapy in hemodialysis patients: a systematic review |
| Q50948476 | Challenges in developing DNA and RNA biomarkers of inflammation. |
| Q44823840 | Changes in serum markers of oxidative stress with varying periods of haemodialysis |
| Q48827149 | Clinically relevant HOCl concentrations reduce clot retraction rate via the inhibition of energy production in platelet mitochondria |
| Q42264458 | Direct measurement of reactive oxygen species in leukocytes during hemodialysis therapy |
| Q38786018 | Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial |
| Q47740115 | Effect of hemodialysis on the antioxidative properties of serum |
| Q42660443 | Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients |
| Q33345061 | Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? |
| Q46418969 | Hypochlorous acid and 3,4-dihydroxyphenylalanine increase the formation of serum protein lipofuscin-like fluorophores in vitro |
| Q37665476 | Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100. |
| Q36890915 | Inconsistency of reported uremic toxin concentrations |
| Q44690165 | Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis |
| Q44395889 | Inhibition of hypochlorous acid-induced oxidative reactions by nitrite: is nitrite an antioxidant? |
| Q37091275 | Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. |
| Q52655540 | MPO promoter polymorphism rs2333227 enhances malignant phenotypes of colorectal cancer by altering the binding affinity of AP-2α. |
| Q35047134 | Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? |
| Q26776397 | Mitochondria: a new therapeutic target in chronic kidney disease |
| Q28074264 | Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins |
| Q50912369 | Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease. |
| Q104472857 | Neutrophil Activation and Neutrophil Extracellular Trap Formation in Dialysis Patients |
| Q35106766 | New insights into the effects of the protein moiety of oxidized LDL (oxLDL) |
| Q84320607 | Nitrite, a reactive nitrogen species, protects human alpha-2-macroglobulin from halogenated oxidant, HOCl |
| Q35053386 | Nitrotyrosine level was associated with mortality in patients with acute kidney injury |
| Q35093664 | Oxidant stress in hemodialysis patients: what are the determining factors? |
| Q64227238 | Oxidative Stress in Animal Models of Acute and Chronic Renal Failure |
| Q48163520 | Oxidative Stress in Kidney Diseases: The Cause or the Consequence? |
| Q89821386 | Oxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of Biomarkers |
| Q51300666 | Plasma cysteine/cystine reduction potential correlates with plasma creatinine levels in chronic kidney disease. |
| Q37604744 | Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial |
| Q38665718 | Role of Hypohalous Acids in Basement Membrane Homeostasis |
| Q26748996 | Role of Myeloperoxidase in Patients with Chronic Kidney Disease |
| Q45544845 | Simultaneous Measurement of 3-Chlorotyrosine and 3,5-Dichlorotyrosine in Whole Blood, Serum and Plasma by Isotope Dilution HPLC-MS-MS. |
| Q47739988 | Sleep apnea syndrome, inflammation and oxidative stress in hemodialysis patients. |
| Q33237048 | Specific sequence motifs direct the oxygenation and chlorination of tryptophan by myeloperoxidase |
| Q26786137 | The balance of powers: Redox regulation of fibrogenic pathways in kidney injury |
| Q53256339 | The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis. |
| Q34178582 | The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors |
| Q37473166 | Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease |
| Q36069621 | Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. |
Search more.